Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...